Hi, what are you looking for?
Jewish Business News
Search results for " Erez Vigodman"
Business
Teva is now close to the 4.6% stake in Mylan that will give it standing in the Netherlands courts.
Business
Mylan has confirmed it will dual list on the TASE and Nasdaq if it acquires Perrigo
Business
Abbott Laboratories (NYSE: ABT), said it would back the generic pharmaceutical company Mylan’s (MYL) $34 billion bid acquisition of Perrigo Co Plc (PRGO.N). Abbott...
Business
A Credit Suisse study finds that most hostile bids fail, especially if antitrust concerns are involved.
empty
Bolt-on acqusition strengthens position in Europe amid three-way takeover battle with Mylan and Teva
Business
In the three way takeover battle Mylan is getting nervous.
Business
Three Way Takeover Battle: believes their offer will win approval from Perrigo stockholders.
Business
Teva Pharmaceutical Industries Ltd. has agreed to pay $1.2 billion in a settlement with the U.S. Federal Trade Commission (FTC), resolving claims that Cephalon...
Business
Teva Pharmaceutical Industries Ltd, an Israeli-based company, has acquired a 1.35 percent stake in Mylan through purchases on the open market, increasing pressure on...
Business
As Israeli pharmaceutical giant Teva pushes ahead with a $40-billion dollar hostile bid for US generic drugmaker Mylan, Brent Saunders, CEO of...